SCHEMBL4820510

SCHEMBL4820510

Cc1nnsc1C(=O)N1CCC(C)(C)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
RAB9A P51151 1/20 0.41
GFER P55789 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SPR P35270 2/20 0.39
MMP1 P03956 1/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
CHRM4 P08173 1/20 0.37
THRB P10828 1/20 0.36
LMNA P02545 1/20 0.36
VNN1 O95497 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4820519 1.00 MAPT (0.43) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL11536904 0.79 RAB9A (0.51) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL11540796 0.78 ALDH1A1 (0.52) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL11542984 0.75 CNR1 (0.49) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL4813107 0.74 ALDH1A1 (0.52) MAPTALDH1A1SPR
SCHEMBL4813097 0.74 ALDH1A1 (0.52) MAPTALDH1A1SPR
SCHEMBL4820516 0.74 MAPT (0.38) MAPTRAB9AGFERALDH1A1POLB
SCHEMBL4429571 0.70 RAB9A (0.44) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL3319619 0.67 MAPT (0.46) MAPTRAB9AGFERALDH1A1KDM4E
SCHEMBL17176300 0.66 SPR (0.45) ALDH1A1SPRTHRBVNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US claimed
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US disclosed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP disclosed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO disclosed